Charles Schwab’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-135,487
Closed -$42.3K 3551
2025
Q1
$42.3K Sell
135,487
-26,321
-16% -$8.21K ﹤0.01% 3420
2024
Q4
$151K Hold
161,808
﹤0.01% 3356
2024
Q3
$191K Hold
161,808
﹤0.01% 3341
2024
Q2
$124K Hold
161,808
﹤0.01% 3464
2024
Q1
$494K Hold
161,808
﹤0.01% 3032
2023
Q4
$521K Sell
161,808
-8,228
-5% -$26.5K ﹤0.01% 3063
2023
Q3
$653K Buy
170,036
+7,389
+5% +$28.4K ﹤0.01% 2943
2023
Q2
$533K Buy
162,647
+127,009
+356% +$417K ﹤0.01% 3019
2023
Q1
$91.9K Buy
35,638
+16,186
+83% +$41.8K ﹤0.01% 3262
2022
Q4
$36.2K Hold
19,452
﹤0.01% 3423
2022
Q3
$36K Hold
19,452
﹤0.01% 3402
2022
Q2
$42K Hold
19,452
﹤0.01% 3416
2022
Q1
$62K Hold
19,452
﹤0.01% 3499
2021
Q4
$63K Hold
19,452
﹤0.01% 3487
2021
Q3
$66K Hold
19,452
﹤0.01% 3417
2021
Q2
$77K Sell
19,452
-99,326
-84% -$393K ﹤0.01% 3312
2021
Q1
$478K Buy
118,778
+10,896
+10% +$43.8K ﹤0.01% 3092
2020
Q4
$250K Buy
107,882
+10,443
+11% +$24.2K ﹤0.01% 3225
2020
Q3
$560K Sell
97,439
-3,412
-3% -$19.6K ﹤0.01% 2844
2020
Q2
$744K Buy
100,851
+82,273
+443% +$607K ﹤0.01% 2713
2020
Q1
$56K Hold
18,578
﹤0.01% 3147
2019
Q4
$78K Buy
+18,578
New +$78K ﹤0.01% 3109
2019
Q3
Sell
-73,229
Closed -$136K 3189
2019
Q2
$136K Sell
73,229
-27,369
-27% -$50.8K ﹤0.01% 3115
2019
Q1
$179K Buy
100,598
+42,127
+72% +$75K ﹤0.01% 3042
2018
Q4
$142K Sell
58,471
-1,216
-2% -$2.95K ﹤0.01% 3059
2018
Q3
$339K Buy
59,687
+24,747
+71% +$141K ﹤0.01% 2970
2018
Q2
$273K Buy
34,940
+645
+2% +$5.04K ﹤0.01% 3005
2018
Q1
$243K Buy
34,295
+13,785
+67% +$97.7K ﹤0.01% 2941
2017
Q4
$203K Buy
20,510
+6,010
+41% +$59.5K ﹤0.01% 2979
2017
Q3
$125K Hold
14,500
﹤0.01% 3051
2017
Q2
$153K Buy
+14,500
New +$153K ﹤0.01% 3064